Literature DB >> 11880573

Dietary oligofructose and inulin protect mice from enteric and systemic pathogens and tumor inducers.

Karyl K Buddington1, Jillian B Donahoo, Randal K Buddington.   

Abstract

Prebiotics induce changes in the population and metabolic characteristics of the gastrointestinal bacteria, modulate enteric and systemic immune functions, and provide laboratory rodents with resistance to carcinogens that promote colorectal cancer. There is less known about protection from other challenges. Therefore, mice of the B6C3F1 strain were fed for 6 wk a control diet with 100 g/kg cellulose or one of two experimental diets with the cellulose replaced entirely by the nondigestible oligosaccharides (NDO) oligofructose and inulin. From each diet, 25 mice were challenged by a promoter of colorectal cancer (1,2-dimethylhydrazine), B16F10 tumor cells, the enteric pathogen Candida albicans (enterically), or were infected systemically with Listeria monocytogenes or Salmonella typhimurium. The incidences of aberrant crypt foci in the distal colon after exposure to dimethylhdrazine for mice fed inulin (53%) and oligofructose (54%) were lower than in control mice (76%; P < 0.05), but the fructans did not reduce the incidence of lung tumors after injection of the B16F10 tumor cells. Mice fed the diets with fructans had 50% lower densities of C. albicans in the small intestine (P < 0.05). A systemic infection with L. monocytogenes caused nearly 30% mortality among control mice, but none of the mice fed inulin died, with survival intermediate for mice fed oligofructose. Mortality was higher for the systemic infection of S. typhimurium (>80% for control mice), but fewer of the mice fed inulin died (60%; P < 0.05), with mice fed oligofructose again intermediate. The mechanistic basis for the increased resistance provided by dietary NDO was not elucidated, but the findings are consistent with enhanced immune functions in response to changes in the composition and metabolic characteristics of the bacteria resident in the gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11880573     DOI: 10.1093/jn/132.3.472

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  21 in total

Review 1.  Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota.

Authors:  C T Peterson; V Sharma; L Elmén; S N Peterson
Journal:  Clin Exp Immunol       Date:  2015-03       Impact factor: 4.330

2.  Identification of a putative operon involved in fructooligosaccharide utilization by Lactobacillus paracasei.

Authors:  Yong Jun Goh; Chaomei Zhang; Andrew K Benson; Vicki Schlegel; Jong-Hwa Lee; Robert W Hutkins
Journal:  Appl Environ Microbiol       Date:  2006-10-06       Impact factor: 4.792

3.  Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells.

Authors:  Kari Shoaf; George L Mulvey; Glen D Armstrong; Robert W Hutkins
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

Review 4.  Applications of inulin and oligofructose in health and nutrition.

Authors:  Narinder Kaur; Anil K Gupta
Journal:  J Biosci       Date:  2002-12       Impact factor: 1.826

5.  Dietary fructooligosaccharides up-regulate immunoglobulin A response and polymeric immunoglobulin receptor expression in intestines of infant mice.

Authors:  Y Nakamura; S Nosaka; M Suzuki; S Nagafuchi; T Takahashi; T Yajima; N Takenouchi-Ohkubo; T Iwase; I Moro
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

6.  Arabinoxylan-oligosaccharides (AXOS) reduce preneoplastic lesions in the colon of rats treated with 1,2-dimethylhydrazine (DMH).

Authors:  Angelo Pietro Femia; Maddalena Salvadori; Willem F Broekaert; Isabelle E J A François; Jan A Delcour; Christophe M Courtin; Giovanna Caderni
Journal:  Eur J Nutr       Date:  2009-08-27       Impact factor: 5.614

7.  A genomic island of an extraintestinal pathogenic Escherichia coli Strain enables the metabolism of fructooligosaccharides, which improves intestinal colonization.

Authors:  Catherine Schouler; Ahmed Taki; Iman Chouikha; Maryvonne Moulin-Schouleur; Philippe Gilot
Journal:  J Bacteriol       Date:  2008-10-31       Impact factor: 3.490

Review 8.  Mycoses in the elderly.

Authors:  H Hof
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-13       Impact factor: 3.267

9.  Effect of Lactobacillus rhamnosus NCDC 298 with FOS in Combination on Viability and Toxin Production of Enterotoxigenic Escherichia coli.

Authors:  Santosh Anand; Surajit Mandal; Sudhir Kumar Tomar
Journal:  Probiotics Antimicrob Proteins       Date:  2019-03       Impact factor: 4.609

10.  Association of Dietary Prebiotic Consumption with Reduced Risk of Alzheimer's Disease in a Multiethnic Population.

Authors:  Mia Nishikawa; Adam M Brickman; Jennifer J Manly; Nicole Schupf; Richard P Mayeux; Yian Gu
Journal:  Curr Alzheimer Res       Date:  2021       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.